News / Events

UROLEAD will present its PDX tumor models at the American Association for Cancer Research (AACR) Annual Meeting 2019 in Atlanta.

Characterization of hormone-sensitive and castrate-resistant phenotypes in prostate cancer patient-derived PDX models generated from the same patient.
Authors: Hervé Lang, Claire Béraud, Myriam Lassalle, Véronique Lindner, Eric Potiron, Philippe Lluel and Thierry Massfelder.
Abstract Number: 3138

High specific characterization of patient-derived tumor xenograft models for accelerating drug development in muscle-invasive bladder cancers.

Authors: Hervé Lang, Claire Béraud, Myriam Lassalle, Véronique Lindner, Michel Soulié, Xavier Gamé, Pascal Rischmann, Yves Allory, François Radvanyi, Isabelle Bernard-Pierrot, Philippe Lluel and Thierry Massfelder.
Abstract Number: 3526

Urolead will present a poster at the 33rd annual EAU congress (16-20 March 2018)

"An extensive panel of patient-derived bladder cancer xenografts representing the various molecular subtypes of muscle-invasive bladder cancers (MIBC)".

It will be a pleasure to meet you during the EAU congress. Don't hesitate to contact us.


Urolead and Urosphere wishes you happiness, good health and success for this new year 2018.


Urosphere / Urolead is proud to be part of the Repositive PDX comsortium.

The full press release can be found here: https://blog.repositive.io/new-global-pdx-directory-introduced-at-aacr-conference/

Urosphere / Urolead will be represented by Repositive’s CEO Fiona Nielsen at the AACR-NIC-EORTC conference in Philadelphia, from Oct 26th to Oct 31st. Come and meet her at booth 817.



Urolead presented its PDX platform at the 24th Meeting of the EAU Section of Urological Research in collaboration with the EAU Section of Uropathology, October 13th 2017.


Urolead is pleased to announce its acquisition by Urosphere company.


PDX tumor models at the American Association for Cancer Research (AACR) Annual Meeting 2016 in New Orleans. Come to see us!



Urolead will be present at BIOFIT business convention in Strasbourg, France, October 1st-2nd, 2015.



October 23th and 24th 2015, UROLEAD will attend and will present data at “6ème Congrès de l’association ARTuR”


Urolead is pleased to announce its participation to the American Association for Cancer Research (AACR) Annual Meeting 2013 in Washington.



European Cancer Cluster Partnering, 14-16 September, 2011


Logo_ECCP Urolead is pleased to announce its presence at the 3th European Cancer Cluster Partnering Meeting, in Toulouse, France.
To schedule a meeting, please contact us



Urolead is mentioned in the CGE newsletter n°12

May 2011: Lettre d'information du cancéropôle Grand-Est - n° 12, Mai 2011

Urolead tumorgrafts collection is expanded

April 2011: Urolead expands its tumorgraft collection

Urolead is pleased to announce the expansion of its prostate, kidney and bladder tumorgraft collection, with 4, 35 and 6 tumors models respectively.

Please contact us if you require further information or have any question


Urosphere / Urolead is proud to be part of the Repositive PDX comsortium.

The full press release can be found here: https://blog.repositive.io/new-global-pdx-directory-introduced-at-aacr-conference/

Urosphere / Urolead will be represented by Repositive’s CEO Fiona Nielsen at the AACR-NIC-EORTC conference in Philadelphia, from Oct 26th to Oct 31st. Come and meet her at booth 817.



Urolead presented its PDX platform at the 24th Meeting of the EAU Section of Urological Research in collaboration with the EAU Section of Uropathology, October 13th 2017.


Urolead is pleased to announce its acquisition by Urosphere company.


PDX tumor models at the American Association for Cancer Research (AACR) Annual Meeting 2016 in New Orleans. Come to see us!



Urolead will be present at BIOFIT business convention in Strasbourg, France, October 1st-2nd, 2015.



October 23th and 24th 2015, UROLEAD will attend and will present data at “6ème Congrès de l’association ARTuR”


Urolead is pleased to announce its participation to the American Association for Cancer Research (AACR) Annual Meeting 2013 in Washington.



European Cancer Cluster Partnering, 14-16 September, 2011


Logo_ECCP Urolead is pleased to announce its presence at the 3th European Cancer Cluster Partnering Meeting, in Toulouse, France.
To schedule a meeting, please contact us



Urolead is mentioned in the CGE newsletter n°12

May 2011: Lettre d'information du cancéropôle Grand-Est - n° 12, Mai 2011

Urolead tumorgrafts collection is expanded

April 2011: Urolead expands its tumorgraft collection

Urolead is pleased to announce the expansion of its prostate, kidney and bladder tumorgraft collection, with 4, 35 and 6 tumors models respectively.

Please contact us if you require further information or have any question